Dr. Pourhassan stated in Thursday's CC on CD10 and
Post# of 148168
I do not recall if this link was posted here or elsewhere, but this describes DSMCs/
https://www.nidcr.nih.gov/research/human-subj...guidelines
I did not see (addressing previous posts) an indication of an extraordinary level of significance need to stop trials.I assume that P<0.05 would suffice.